Merck ramping up Durham vax campus, plans new lab

While Merck has been cutting down on its workforce following its mega-merger with Schering-Plough, the Big Pharma company has been steadily ramping up its vaccine operations in Durham, NC.

Payroll at its main vaccine operation is expected to swell from 275 today to some 400 by the end of the year. And this August, Merck will break ground on a 40,000-square-foot testing lab that is slated to open in 2012 with 50 to 60 workers. Work on the campus was launched back in 2004, and Merck is expecting to gain approvals to start selling the vaccines it makes there later this summer.

The region bet big on Merck when it first floated the idea of building a vaccine complex in the area. Merck stands to gain $45 million in hiring incentives if it hits its projected workforce levels. Pfizer, meanwhile, recently announced that it would lay off 50 workers in Durham as it absorbs Wyeth.

- here's the story from the News & Observer
-
read more about Pfizer

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.